Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.5700
-0.1189 (-17.26%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $53 million as of July 20, 2026. Its market cap has decreased by -55.80% in one year.
Market Cap
53.00M
Enterprise Value
54.17M
1-Year Change
-55.80%
Ranking
Category
Stock Price
$0.57
ChartMarket Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $53.00M, a decrease of -41.25%. That is a compound annual growth rate of -13.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 53.00M | -37.50% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 139.05M |
| Organigram Global | 125.60M |
| BGM Group | 108.16M |
| Cumberland Pharmaceuticals | 102.48M |
| China SXT Pharmaceuticals | 78.93M |
| Talphera | 68.77M |
| InterCure | 51.26M |
| China Pharma Holdings | 44.57M |